Tirzepatide 10mg
GLP-1 / Weight LossThe heavyweight dual GIP/GLP-1 agonist - built for users who plateaued on semaglutide and want more.
science
Standard Reference Dosing
Vial Strength
10mg
BAC Water
2mL
Dose / Injection
2.5mg
Schedule
Weekly
Typical Cycle
Typically run continuously for 12+ weeks with gradual titration; often continued long-term.
Draw Amount
50 units
Community Reported Benefits
- Dual GIP and GLP-1 activation drives faster, deeper fat loss than single-pathway GLP-1 compounds.
- Shuts down appetite and food cravings hard enough that skipping a meal stops feeling like a struggle.
- Strips visceral belly fat and improves insulin sensitivity, often outperforming semaglutide at matched doses.
Things to Watch For
- Nausea and GI discomfort, often stronger than single-agonist GLP-1s
- Appetite suppression that can feel intense at higher doses
- Occasional fatigue during dose increases
- Injection site irritation in some users
schedule Best Time to Take (Community Consensus)
Morning or evening, on the same day each week.
Mechanism of Action
Activates both GIP and GLP-1 receptors simultaneously, doubling the appetite and blood-sugar signaling pathway that single-agonist GLP-1s only hit once.
Technical Reference
Half-life
~5 days
Mol. Weight
4,813.5 g/mol
ac_unit Storage & Handling
Refrigerate the unmixed vial; after reconstitution, keep refrigerated and use within 30 days for best potency.
Reconstitution steps & injection technique arrow_forward
Compiled from community-reported research protocols for informational purposes. Not medical advice. Consult a licensed physician before starting any research or personal protocol.